Furoscix is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Scpharmaceuticals Inc.. The primary component is Furosemide.
| Product ID | 71767-100_eb84f893-f572-29f8-e053-2995a90a5e1e |
| NDC | 71767-100 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Furoscix |
| Generic Name | Furosemide Injection 80 Mg/ 10 Ml |
| Dosage Form | Injection |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2022-11-14 |
| Marketing Category | NDA / |
| Application Number | NDA209988 |
| Labeler Name | scPharmaceuticals Inc. |
| Substance Name | FUROSEMIDE |
| Active Ingredient Strength | 8 mg/mL |
| Pharm Classes | Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-11-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FUROSCIX 87101278 5287573 Live/Registered |
scPharmaceuticals Inc. 2016-07-12 |